Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT06972641 Clinical Landscape Report 2026
15 October 2026
NCT06972641 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Normal Human Immunoglobulin (CSL Behring) in Common Variable Immunodeficiency: NCT06976476 Clinical Landscape Report 2026
15 October 2026
NCT06976476 clinical landscape for Common Variable Immunodeficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Albumin-Bound Paclitaxel in Recurrent Triple-Negative Breast Carcinoma: NCT06976944 Clinical Landscape Report 2026
15 October 2026
NCT06976944 clinical landscape for Recurrent Triple-Negative Breast Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Odronextamab in Lupus Nephritis: NCT06975787 Clinical Landscape Report 2026
15 October 2026
NCT06975787 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ABBV-319 in Sjogren's Syndrome: NCT06977724 Clinical Landscape Report 2026
15 October 2026
NCT06977724 clinical landscape for Sjogren's Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YTS-109 in Granulomatosis With Polyangiitis: NCT06978647 Clinical Landscape Report 2026
15 October 2026
NCT06978647 clinical landscape for Granulomatosis With Polyangiitis: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
STC-15 in Solid tumor: NCT06975293 Clinical Landscape Report 2026
15 October 2026
NCT06975293 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Chemotherapy-induced nausea and vomiting: NCT06975644 Clinical Landscape Report 2026
15 October 2026
NCT06975644 clinical landscape for Chemotherapy-induced nausea and vomiting: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
PF-08046037 in Pancreatic Ductal Adenocarcinoma: NCT06974734 Clinical Landscape Report 2026
15 October 2026
NCT06974734 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Lenalidomide in Residual Neoplasm: NCT06974786 Clinical Landscape Report 2026
15 October 2026
NCT06974786 clinical landscape for Residual Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivonescimab in Triple Negative Breast Cancer: NCT06977542 Clinical Landscape Report 2026
15 October 2026
NCT06977542 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Ovarian Cancer: NCT06977594 Clinical Landscape Report 2026
15 October 2026
NCT06977594 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.